Fineline Cube

Follow:
14452 Articles
CompanyDrug

Adlai Nortye’s AN4035 Receives Australian Regulatory Approvals for First-in-Class Pan-RAS(ON) ADC

CompanyDrug

Zai Lab’s Zocilurtatug Pelitecan Receives FDA Orphan Drug Designation for Neuroendocrine Carcinoma

Drug

FDA Grants Biologics License to Ezplaz Freeze-Dried Plasma, First FDP Approved in United States

CompanyDrug

Novartis’ Pluvicto Receives FDA Approval for Metastatic Hormone-Sensitive Prostate Cancer

HutchMed Reports H1 2026 Results with Strong Oncology Growth Despite Overall Revenue Decline
Company

HutchMed Reports H1 2026 Results with Strong Oncology Growth Despite Overall Revenue Decline

CompanyDeals

Siemens Healthineers and Cleveland Clinic Announce 10-Year Strategic Partnership

CompanyDeals

Apeloa Pharmaceutical and METiS Therapeutics Announce Strategic CDMO Partnership

CompanyMedical Device

Sansure Biotech Secures EU IVDR CE Certification for Five Nucleic Acid Diagnostic Kits

CompanyDrug

Sino Biopharmaceutical’s TQB2102 Receives Breakthrough Therapy Designation from NMPA for HER2-Low Breast Cancer

Suzhou Forlong Biotechnology Advances FL115 Subcutaneous Injection into Phase 1 Clinical Trial for Advanced Solid Tumors
CompanyDrug

Suzhou Forlong Biotechnology Advances FL115 Subcutaneous Injection into Phase 1 Clinical Trial for Advanced Solid Tumors

CompanyDrug

Shaanxi Micot Pharmaceutical Announces Positive Phase 2 Results for MT200605 in Acute Ischemic Stroke

CompanyDrug

CSPC Pharmaceutical Launches Phase Ib/II Trial of Novel SYS6090 Fusion Protein for Colorectal Cancer